Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Weave Communications
WEAV
$520M
| $974K | ﹤0.01% |
87,702
+4,019
| +5% | +$26.8K |
|
2777
Voyager Therapeutics
VYGR
$182M
| $974K | ﹤0.01% |
85,055
+72,609
| +583% | +$751K |
|
|
SMLR
2778
DELISTED
Semler Scientific
SMLR
| $971K | ﹤0.01% |
37,019
+11,556
| +45% | +$304K |
|
2779
AerSale
ASLE
$292M
| $971K | ﹤0.01% |
66,069
+2,729
| +4% | +$43.8K |
|
2780
Business First Bancshares
BFST
$1.04B
| $970K | ﹤0.01% |
64,355
+1,392
| +2% | +$21.5K |
|
2781
Tiptree Inc
TIPT
$655M
| $968K | ﹤0.01% |
64,520
-1,012
| -2% | -$14.1K |
|
2782
Gevo
GEVO
$360M
| $967K | ﹤0.01% |
636,323
+87,814
| +16% | +$114K |
|
2783
Accuray
ARAY
$31.6M
| $967K | ﹤0.01% |
249,865
+172,247
| +222% | +$597K |
|
2784
Commercial Vehicle Group
CVGI
$151M
| $964K | ﹤0.01% |
86,851
+73,434
| +547% | +$666K |
|
|
AKYA
2785
DELISTED
Akoya BioSciences
AKYA
| $963K | ﹤0.01% |
130,307
+6,294
| +5% | +$42K |
|
|
BLUE
2786
DELISTED
bluebird bio
BLUE
| $961K | ﹤0.01% |
14,603
+2,939
| +25% | +$215K |
|
|
FFAI
2787
Faraday Future Intelligent Electric
FFAI
$18.6M
| $958K | ﹤0.01% |
3
| – | – |
|
2788
NuScale Power
SMR
$2.92B
| $958K | ﹤0.01% |
140,821
+61,660
| +78% | +$500K |
|
2789
Xeris Biopharma Holdings
XERS
$1.39B
| $956K | ﹤0.01% |
365,013
-9,978
| -3% | -$25.4K |
|
2790
iRadimed
IRMD
$1.2B
| $953K | ﹤0.01% |
19,962
+613
| +3% | +$27.6K |
|
2791
Burke & Herbert Financial Services Corp
BHRB
$1.47B
| $945K | ﹤0.01% |
+14,714
| New | +$1.16M |
|
2792
Carter Bankshares
CARE
$756M
| $944K | ﹤0.01% |
63,841
-734
| -1% | -$10.4K |
|
2793
Independent Bank Corp
IBCP
$789M
| $944K | ﹤0.01% |
55,664
+562
| +1% | +$9.63K |
|
2794
Workhorse Group
WKHS
$34M
| $940K | ﹤0.01% |
360
-42
| -10% | -$121K |
|
2795
Rio Tinto
RIO
$157B
| $939K | ﹤0.01% |
14,715
+8,249
| +128% | +$530K |
|
|
QUOT
2796
DELISTED
Quotient Technology Inc
QUOT
| $935K | ﹤0.01% |
243,426
-917
| -0.4% | -$2.85K |
|
2797
Cipher Digital
CIFR
$9B
| $929K | ﹤0.01% |
324,825
+23,708
| +8% | +$58.4K |
|
2798
Alta Equipment Group
ALTG
$210M
| $929K | ﹤0.01% |
53,589
-3,705
| -6% | -$54.7K |
|
|
TVRD
2799
Tvardi Therapeutics
TVRD
$19M
| $927K | ﹤0.01% |
9,095
-235
| -3% | -$32.4K |
|
|
MOND
2800
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $925K | ﹤0.01% |
+103,793
| New | +$1.06M |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.